bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.07.21.666053

Individual differences in perceptual capacity depend on aperiodic slope, not alpha oscillations

Abstract

Visual processing is subject to strict capacity limitations that restrict the number of stimuli that can be individuated, that is, distinguished as separate objects, to around 3-4 items at a time. The neural mechanisms that give rise to this subitizing limit are unclear. Here, we tested an account of the subitizing limit that attributes it to the amount of information that can be processed within one cycle of the 8-14 Hz alpha oscillation. This account proposes that the subitizing limit should be correlated with an individuals alpha oscillation frequency. We pitted this account against one based on neural excitatory-inhibitory balance, as indexed by the slope of the aperiodic component of the electrophysiological power spectrum. To test these accounts, we had human participants (N=51; 37 females) complete a visual enumeration task while we measured their brain activity with electroencephalography (EEG). We extracted aperiodic and alpha-band activity from the pre-stimulus period and correlated these with model-based estimates of individuals subitizing capacity. Alpha oscillations were not correlated with subitizing capacity within-participants or as individual differences, but they were associated with other elements of enumeration performance, including baseline reaction times and the slope of the performance decrement outside the subitizing range. By contrast, individual differences in aperiodic slope reliably predicted individuals subitizing capacity. These results suggest that differences in neural excitatory:inhibitory balance are the source of individuation-related capacity limits, not alpha-frequency sampling. Significance StatementBusy, multi-element visual scenes are common in daily life. Human visual perception, however, is capacity limited, individuating only 3-4 objects at a time. The source of these capacity limitations is currently unknown. This work examines the neural correlates of perceptual capacity within and between individuals, comparing a rhythmic pulsed inhibition account with one based on the arhythmic balance of neural excitation and inhibition. Our results demonstrate that individuals with more arhythmic inhibition demonstrate greater perceptual capacity. These results help to explain how excitation and inhibition across populations of neurons sculpts the capacity of the neural system and suggest targets for future interventions to improve perceptual capacity with arhythmic brain stimulation.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Elliott, J. A., Mattingley, J. B., Eayrs, J. O., Harris, A. M.. 2025-07-25. Individual differences in perceptual capacity depend on aperiodic slope, not alpha oscillations. https://doi.org/10.1101/2025.07.21.666053

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗